Alvogen nabs four Pfizer products; Brazil's pharma market to approach $48B by 2020: report;

> Alvogen has acquired a portfolio of four pharma products from Pfizer ($PFE). Release

> Brazil's pharma market will near $48 billion by 2020, GlobalData says. Release

> Amneal has created a new biosciences unit that will focus on injectables, oncologics, biosimilars and other products that have high barriers to entry. Release

> Mylan ($MYL) has launched a generic of Pfizer's anti-infective combo Zosyn. Release

> British health secretary Jeremy Hunt is to create tough new rules designed to criminalize some gifts and financial payments between doctors and pharma companies. Report

Suggested Articles

Esperion's Nexletol has had a rough road to approval after safety concerns nearly derailed its quest. But an FDA nod has the drug ready for market.

Nerlynx is already struggling in its extended adjuvant breast cancer setting, and new entrants from Daiichi-AZ and SeaGen could pressure it elsewhere.

Eli Lilly is joining Team USA as an official sponsor for the first time, backing Olympic and Paralympic athletes headed to Tokyo this summer.